PBAC Public Summary Documents - March 2010

Public summary documents relating to the March 2010 PBAC meeting

Page last updated: 16 July 2010

• Adalimumab, injection, 20 mg in 0.4 mL, 40 mg in 0.8 mL, pre-filled syringe, Humira® - March 2010
• Aprepitant, pack containing 1 capsule 125 mg and 2 capsules 80 mg, Emend® - March 2010
• Bortezomib, powder for injection, 1 mg, Velcade®, March 2010
• Botulinum Toxin Type A Purifed Neurotoxin Complex, lyophilised powder for IM injection, 100 units, Botox® - March 2010
• Brinzolamide with timolol maleate, eye drops, 10 mg -5 mg (base) per mL, (1%-0.5%), Azarga® - March 2010
• Capecitabine, tablet, 150 mg and 500 mg, Xeloda® - March 2010
• Certolizumab Pegol, injection, 200 mg in 1 mL, single use pre-filled syringe, Cimzia® - March 2010
• Cetuximab, solution for IV infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux® - March 2010
• Elitriptan Hydrobromide tablet, 40 mg (base) and 80 mg (base), Relpax® - March 2010
• Golimumab, injection, 50 mg in 0.5 mL, pre-filled syringe, single use pre-filled pen, Simponi® - March 2010 (AS)
• Golimumab, injection, 50 mg in 0.5 mL, pre-filled syringe, single use pre-filled pen, Simponi® - March 2010 (PSA)
• Golimumab, injection 50 mg in 0.5 mL, pre-filled syringe, single use pre-filled pen, Simponi® March 2010 (RA)
• Infliximab, powder for IV infusion, 100 mg, Remicade® - March 2010
• Nicotine, transdermal patch, releasing 15 mg per 16 hours, Nicorette® - March 2010
• Palonosetron Hydrochloride, solution for injection vial, 250 micrograms in 5 mL, Onicit® - March 2010
• Pemetrexed Disodium, powder for I.V. infusion, 100 mg (base) and 500 mg (base), Alimta®
• Perindopril Arginine with Amlodipine Besylate, tablet, 5 mg-5 mg, 5 mg-10 mg, 10 mg-5 mg and 10 mg-10 mg, Coveram® - March 2010
• Raltegravir Potassium, tablet 400 mg (base), Isentress® - March 2010
• Rituximab, solution for IV infusion, 100 mg in 10 mL and 500 mg in 50 mL, Mabthera®- March 2010
• Romiplostim, powder for injection, 165 micrograms, 375 micrograms and 625 micrograms, Nplate® - March 2010
• Salbutamol Sulfate, oral pressurised inhalation, 100 micrograms (base) per dose (200 doses), CFC-free formulation with spacer, VentSpacer®
• Saxagliptin, tablets, 5 mg, Onglyza® - March 2010
• Tocilizumab, solution for IV infusion, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra® - March 2010
• Vildagliptin, tablet, 50 mg, Galvus® - March 2010